Literature DB >> 28374858

Sulfotransferase 1A3/4 copy number variation is associated with neurodegenerative disease.

N J Butcher1, M K Horne2, G D Mellick3, C J Fowler2, C L Masters2, R F Minchin1.   

Abstract

The cytosolic aryl sulfotransferase genes SULT1A3 and SULT1A4 are located on chromosome 16p11.2 in a region of chromosomal instability. SULT1A3/4 are important enzymes in the metabolism of catecholamines linked to neurodegenerative diseases such as Parkinson's and Alzheimer's. In the present study, copy number variation of the SULT1A3/4 genes in healthy individuals, as well as a cohort of Parkinson's disease and Alzheimer's disease patients was examined. In all subjects, SULT1A3/4 copy number varied from 1 to 10. In Alzheimer's disease patients, there was a significantly lower copy number compared to controls, and a positive correlation between copy number and age of disease onset. By contrast, there were no differences in Parkinson's disease patients. However, when early-onset Parkinson's disease was evaluated separately, there appeared to be an association with gene copy number and risk. The current study shows that these neurodegenerative diseases may be related to SULT1A3/4 copy number.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28374858     DOI: 10.1038/tpj.2017.4

Source DB:  PubMed          Journal:  Pharmacogenomics J        ISSN: 1470-269X            Impact factor:   3.550


  52 in total

1.  Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease.

Authors:  Victor L Villemagne; Kerryn E Pike; Gaël Chételat; Kathryn A Ellis; Rachel S Mulligan; Pierrick Bourgeat; Uwe Ackermann; Gareth Jones; Cassandra Szoeke; Olivier Salvado; Ralph Martins; Graeme O'Keefe; Chester A Mathis; William E Klunk; David Ames; Colin L Masters; Christopher C Rowe
Journal:  Ann Neurol       Date:  2011-01       Impact factor: 10.422

Review 2.  Genetics of Parkinson's disease.

Authors:  Christine Klein; Ana Westenberger
Journal:  Cold Spring Harb Perspect Med       Date:  2012-01       Impact factor: 6.915

Review 3.  Sulfotransferase gene copy number variation: pharmacogenetics and function.

Authors:  S J Hebbring; A M Moyer; R M Weinshilboum
Journal:  Cytogenet Genome Res       Date:  2009-03-11       Impact factor: 1.636

4.  Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer's disease.

Authors:  Gaël Chételat; Victor L Villemagne; Kerryn E Pike; Kathryn A Ellis; Pierrick Bourgeat; Gareth Jones; Graeme J O'Keefe; Olivier Salvado; Cassandra Szoeke; Ralph N Martins; David Ames; Colin L Masters; Christopher C Rowe
Journal:  Brain       Date:  2011-02-09       Impact factor: 13.501

5.  Chromosomal 16p microdeletion in Rubinstein-Taybi syndrome detected by oligonucleotide-based array comparative genomic hybridization: a case report.

Authors:  Md A Mohd Fadley; Azli Ismail; Thong Meow Keong; Narazah Mohd Yusoff; Zubaidah Zakaria
Journal:  J Med Case Rep       Date:  2012-01-23

6.  A single amino acid, glu146, governs the substrate specificity of a human dopamine sulfotransferase, SULT1A3.

Authors:  R Dajani; A M Hood; M W Coughtrie
Journal:  Mol Pharmacol       Date:  1998-12       Impact factor: 4.436

7.  Recurrent reciprocal 16p11.2 rearrangements associated with global developmental delay, behavioural problems, dysmorphism, epilepsy, and abnormal head size.

Authors:  Marwan Shinawi; Pengfei Liu; Sung-Hae L Kang; Joseph Shen; John W Belmont; Daryl A Scott; Frank J Probst; William J Craigen; Brett H Graham; Amber Pursley; Gary Clark; Jennifer Lee; Monica Proud; Amber Stocco; Diana L Rodriguez; Beth A Kozel; Steven Sparagana; Elizabeth R Roeder; Susan G McGrew; Thaddeus W Kurczynski; Leslie J Allison; Stephen Amato; Sarah Savage; Ankita Patel; Pawel Stankiewicz; Arthur L Beaudet; Sau Wai Cheung; James R Lupski
Journal:  J Med Genet       Date:  2009-11-12       Impact factor: 6.318

8.  Cytosolic sulfotransferase 1A3 is induced by dopamine and protects neuronal cells from dopamine toxicity: role of D1 receptor-N-methyl-D-aspartate receptor coupling.

Authors:  Neelima P Sidharthan; Rodney F Minchin; Neville J Butcher
Journal:  J Biol Chem       Date:  2013-10-17       Impact factor: 5.157

9.  Speech delays and behavioral problems are the predominant features in individuals with developmental delays and 16p11.2 microdeletions and microduplications.

Authors:  Jill A Rosenfeld; Justine Coppinger; Bassem A Bejjani; Santhosh Girirajan; Evan E Eichler; Lisa G Shaffer; Blake C Ballif
Journal:  J Neurodev Disord       Date:  2010-03       Impact factor: 4.025

10.  Microduplications of 16p11.2 are associated with schizophrenia.

Authors:  Shane E McCarthy; Vladimir Makarov; George Kirov; Anjene M Addington; Jon McClellan; Seungtai Yoon; Diana O Perkins; Diane E Dickel; Mary Kusenda; Olga Krastoshevsky; Verena Krause; Ravinesh A Kumar; Detelina Grozeva; Dheeraj Malhotra; Tom Walsh; Elaine H Zackai; Paige Kaplan; Jaya Ganesh; Ian D Krantz; Nancy B Spinner; Patricia Roccanova; Abhishek Bhandari; Kevin Pavon; B Lakshmi; Anthony Leotta; Jude Kendall; Yoon-Ha Lee; Vladimir Vacic; Sydney Gary; Lilia M Iakoucheva; Timothy J Crow; Susan L Christian; Jeffrey A Lieberman; T Scott Stroup; Terho Lehtimäki; Kaija Puura; Chad Haldeman-Englert; Justin Pearl; Meredith Goodell; Virginia L Willour; Pamela Derosse; Jo Steele; Layla Kassem; Jessica Wolff; Nisha Chitkara; Francis J McMahon; Anil K Malhotra; James B Potash; Thomas G Schulze; Markus M Nöthen; Sven Cichon; Marcella Rietschel; Ellen Leibenluft; Vlad Kustanovich; Clara M Lajonchere; James S Sutcliffe; David Skuse; Michael Gill; Louise Gallagher; Nancy R Mendell; Nick Craddock; Michael J Owen; Michael C O'Donovan; Tamim H Shaikh; Ezra Susser; Lynn E Delisi; Patrick F Sullivan; Curtis K Deutsch; Judith Rapoport; Deborah L Levy; Mary-Claire King; Jonathan Sebat
Journal:  Nat Genet       Date:  2009-10-25       Impact factor: 38.330

View more
  7 in total

1.  Analyses of the genetic diversity and protein expression variation of the acyl: CoA medium-chain ligases, ACSM2A and ACSM2B.

Authors:  Rencia van der Sluis
Journal:  Mol Genet Genomics       Date:  2018-06-14       Impact factor: 3.291

2.  Oxysterols and Oxysterol Sulfates in Alzheimer's Disease Brain and Cerebrospinal Fluid.

Authors:  Irundika H K Dias; Hala Shokr; Freya Shephard; Lisa Chakrabarti
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

3.  Sulfation modification of dopamine in brain regulates aggregative behavior of animals.

Authors:  Bing Chen; Xiwen Tong; Xia Zhang; Wanying Gui; Guoming Ai; Lihua Huang; Ding Ding; Jiangxu Zhang; Le Kang
Journal:  Natl Sci Rev       Date:  2021-09-02       Impact factor: 23.178

Review 4.  SULT genetic polymorphisms: physiological, pharmacological and clinical implications.

Authors:  Katsuhisa Kurogi; Mohammed I Rasool; Fatemah A Alherz; Amal A El Daibani; Ahsan F Bairam; Maryam S Abunnaja; Shin Yasuda; Lauren J Wilson; Ying Hui; Ming-Cheh Liu
Journal:  Expert Opin Drug Metab Toxicol       Date:  2021-06-30       Impact factor: 4.936

5.  Robust Sampling of Defective Pathways in Alzheimer's Disease. Implications in Drug Repositioning.

Authors:  Juan Luis Fernández-Martínez; Óscar Álvarez-Machancoses; Enrique J de Andrés-Galiana; Guillermina Bea; Andrzej Kloczkowski
Journal:  Int J Mol Sci       Date:  2020-05-19       Impact factor: 5.923

6.  Fluorinated Phosphoadenosine 5'-Phosphosulfate Analogues for Continuous Sulfotransferase Activity Monitoring and Inhibitor Screening by 19F NMR Spectroscopy.

Authors:  Agnieszka Mlynarska-Cieslak; Mikolaj Chrominski; Tomasz Spiewla; Marek R Baranowski; Marcelina Bednarczyk; Jacek Jemielity; Joanna Kowalska
Journal:  ACS Chem Biol       Date:  2022-02-23       Impact factor: 5.100

7.  Link between short tandem repeats and translation initiation site selection.

Authors:  Masoud Arabfard; Kaveh Kavousi; Ahmad Delbari; Mina Ohadi
Journal:  Hum Genomics       Date:  2018-10-29       Impact factor: 4.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.